Keyphrases
Inflammatory Bowel Disease
100%
Novel Therapeutics
100%
Small-molecule Drug Discovery
100%
Crohn's Disease
40%
Corticosteroids
20%
Mechanism of Action
20%
Signaling Pathway
20%
Neoplastic Transformation
20%
Chronic Disease
20%
G Protein-coupled Receptor
20%
Therapeutic Potential
20%
Small Molecules
20%
Preclinical Development
20%
Therapeutic Targeting
20%
Chronic Inflammation
20%
Fibrosis
20%
Tumor Necrosis Factor-α
20%
Ulcerative Colitis
20%
Receptor-interacting Protein Kinase 1 (RIPK1)
20%
Severe Disease
20%
Immune Cells
20%
Biologically Relevant
20%
C-X-C Chemokine Receptor Type 4 (CXCR4)
20%
Drug Discovery
20%
Recent Advances
20%
Integrin
20%
Distinct Mechanism
20%
Mode of Action
20%
Structure-activity Relationship
20%
Gastrointestinal Tract Disease
20%
Recurrent Symptoms
20%
Long-term Persistence
20%
Inflammasome
20%
Disease Management
20%
Mucosal Inflammation
20%
Non-selective
20%
Epigenetic Regulators
20%
Bromodomain-containing Protein 4 (BRD4)
20%
Opportunistic Infections
20%
Recent Introduction
20%
Clinical Development
20%
CCR9
20%
In Vivo Activity
20%
Stricture
20%
In Vitro-in Vivo
20%
Anti-tumor Necrosis Factor Antibody
20%
NOD-like Receptor Protein 3 (NLRP3)
20%
Transmural Inflammation
20%
Janus Kinase
20%
Phosphodiesterase-4 (PDE4)
20%
Intracellular Enzymes
20%
Chemotype
20%
Colitis-associated Colorectal Cancer
20%
Antibodies Neutralizing
20%
Kinase Receptors
20%
Biological Response Modifiers
20%
Action Structure
20%
Primary Nonresponse
20%
Secondary Loss of Response
20%
Inflammatory Bowel Disease Treatment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Inflammatory Bowel Disease
100%
Inflammation
33%
Crohn's Disease
33%
Symptom
16%
Malignant Neoplasm
16%
Chronic Disease
16%
Disease
16%
Receptor
16%
G Protein Coupled Receptor
16%
Colorectal Cancer
16%
Structure Activity Relationship
16%
Ulcerative Colitis
16%
Phosphotransferase
16%
Tumor Necrosis Factor
16%
Chronic Inflammation
16%
Anti-Inflammatory Drug
16%
Combination Therapy
16%
Neutralizing Antibody
16%
Inflammasome
16%
Colitis
16%
Integrin
16%
Cell Enzyme
16%
Opportunistic Infection
16%
Tumor Necrosis Factor Antibody
16%
Phosphodiesterase IV
16%
Biological Response Modifier
16%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Crohn's Disease
33%
Signal Transduction
16%
Mediator
16%
Epigenetics
16%
Immunocompetent Cell
16%
Tumor Necrosis Factor
16%
CXCR4
16%
Structure Activity Relation
16%
Neutralizing Antibody
16%
Integrin
16%
Gastrointestinal Tract
16%
Ulcerative Colitis
16%
Colitis
16%
Inflammasome
16%
Opportunistic Infection
16%
CCR9
16%
Tumor Necrosis Factor Antibody
16%
Chemotype
16%
Biological Response Modifier
16%